Product Details

Trilotab 30 mg Chewable Tablets for Dogs

• MA holder: CP Pharma Handelsgesellschaft mbH
• VM number: 20916/5008
• Territory: Great Britain
• Aligned product: View aligned product details
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Public Assessment Report
  • View Post Authorisation Assessment
• Date of issue: 18/09/2023
• Authorisation route: National
• Active substances:
  • Trilostane
• Controlled drug: No
• Target species:
  • Dogs
• Distribution category: POM-V
• Distributors:
  • Virbac Ltd